OPKO Health Files 8-K: Material Agreement & Equity Sales
Ticker: OPK · Form: 8-K · Filed: Apr 1, 2025 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale
TL;DR
OPKO Health inked a big deal and sold some stock, filing an 8-K on March 28.
AI Summary
On March 28, 2025, OPKO Health, Inc. entered into a material definitive agreement and reported unregistered sales of equity securities. The company, incorporated in Delaware with its principal executive offices in Miami, Florida, filed this 8-K report on April 1, 2025.
Why It Matters
This filing indicates significant corporate actions, including a material definitive agreement and unregistered equity sales, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities, which can sometimes indicate financial pressure or dilution for existing shareholders.
Key Numbers
- 001-33528 — SEC File Number (Identifies the company's filing history with the SEC.)
- 75-2402409 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- OPKO Health, Inc. (company) — Registrant
- March 28, 2025 (date) — Date of earliest event reported
- April 1, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
- Miami, Florida (location) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by OPKO Health, Inc. on March 28, 2025?
The filing states that OPKO Health, Inc. entered into a 'Material Definitive Agreement' on March 28, 2025, but the specific details of this agreement are not provided in the provided text.
What were the circumstances of the unregistered sales of equity securities reported by OPKO Health, Inc.?
The filing indicates 'Unregistered Sales of Equity Securities' occurred, but the specifics of these sales, including the amount and terms, are not detailed in the provided excerpt.
When was OPKO Health, Inc. incorporated and where are its principal executive offices located?
OPKO Health, Inc. was incorporated in Delaware and its principal executive offices are located at 4400 Biscayne Blvd., Miami, Florida, 33137.
What is the SEC file number and IRS Employer Identification Number for OPKO Health, Inc.?
The SEC file number for OPKO Health, Inc. is 001-33528, and its IRS Employer Identification Number is 75-2402409.
What is the SIC code for OPKO Health, Inc.?
The Standard Industrial Classification (SIC) code for OPKO Health, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding OPKO HEALTH, INC. (OPK).